HOME >> BIOLOGY >> NEWS
Gene therapy and sickle cell disease: Religious perspectives

Religious leaders, including prominent African American church leaders, comment on progress toward gene therapy for sickle cell disease, to be reported in "Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy," by R. Pawliuk et al., in the 14 Decemeber 2001 issue of Science, which is EMBARGOED UNTIL 13-DECEMBER-2001 AT 14:00 ET US.

This release contains quotes from carefully selected, well-informed religious leaders. All quotes are free to use by journalists in any news medium. Contact information is provided and follow-up interviews are encouraged.

1. Rev. Dr. Peter J. Paris is the Elmer G. Homrighausen Professor of Christian Social Ethics at Princeton Theological Seminary, and Princeton University African American Studies Program (liaison) He is a past president of the American Academy of Religion and of the Society of Christian Ethics. 609-497-3796 or 609-497-4718.

The millions of people who suffer from sickle cell disease are always happy to learn about research endeavors aimed at treating this genetic disorder. Thanks to the findings of genetic research on mice it is now conceivable that a possible therapy for this dreadful disease is on the horizon. Both sufferers and carriers delight in that prospect. I vividly remember a young couple who discovered late in their courtship that they were both carriers of the sickle cell trait. They were forced to deal with the choice between not marrying or not having children. Both were tragic decisions for them to make. Similarly, and even more sadly, I recall a brilliant young teacher in Ghana who, at 23 years old, was taken to the hospital one night by his parents to be treated for what everyone assumed was malaria, the symptoms of which are similar to the traumas associated with sickle cell disease. Much to the shock of his family and friends, he died that night. In short, people with sickle cell disease in their families live lives that are constantly
'"/>

Contact: Brent Waters
srns@science-spirit.org
412-585-0842
Science and Religion Information Service
13-Dec-2001


Page: 1 2 3 4

Related biology news :

1. Targeted therapy knocks out pediatric brain cancer in mice
2. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
3. Columbia research to examine gene influence on severity of peridontal disease, therapy response
4. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
5. The search for a kinder, gentler chemotherapy
6. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
7. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
8. Gene changes linked to increased eye pressure may have implications for glaucoma therapy
9. Jefferson Lab detector technology aids development of cystic fibrosis therapy
10. Stroking up cellular therapy
11. Smart gene therapy protects against damage from heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: